Sivia Capital Partners LLC acquired a new stake in shares of Cabot Corporation (NYSE:CBT - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,719 shares of the specialty chemicals company's stock, valued at approximately $279,000.
Other hedge funds have also recently made changes to their positions in the company. D. E. Shaw & Co. Inc. grew its stake in shares of Cabot by 221.1% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 18,346 shares of the specialty chemicals company's stock worth $1,675,000 after acquiring an additional 12,633 shares during the period. Quantinno Capital Management LP lifted its holdings in Cabot by 69.9% during the fourth quarter. Quantinno Capital Management LP now owns 4,381 shares of the specialty chemicals company's stock valued at $400,000 after purchasing an additional 1,803 shares during the last quarter. ProShare Advisors LLC boosted its position in Cabot by 36.6% during the fourth quarter. ProShare Advisors LLC now owns 18,319 shares of the specialty chemicals company's stock worth $1,673,000 after purchasing an additional 4,905 shares during the period. Two Sigma Investments LP increased its stake in shares of Cabot by 94.1% in the fourth quarter. Two Sigma Investments LP now owns 82,163 shares of the specialty chemicals company's stock worth $7,502,000 after purchasing an additional 39,830 shares in the last quarter. Finally, Two Sigma Advisers LP raised its position in shares of Cabot by 123.3% in the fourth quarter. Two Sigma Advisers LP now owns 9,600 shares of the specialty chemicals company's stock valued at $877,000 after purchasing an additional 5,300 shares during the period. 93.18% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other Cabot news, CEO Sean D. Keohane sold 114,436 shares of the company's stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $79.28, for a total value of $9,072,486.08. Following the transaction, the chief executive officer directly owned 361,518 shares in the company, valued at $28,661,147.04. This represents a 24.04% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 3.03% of the stock is currently owned by insiders.
Cabot Price Performance
Shares of CBT stock traded down $1.23 during trading hours on Monday, reaching $76.28. The stock had a trading volume of 242,766 shares, compared to its average volume of 306,579. The stock's fifty day simple moving average is $78.25 and its 200 day simple moving average is $78.01. The firm has a market capitalization of $4.06 billion, a PE ratio of 9.97 and a beta of 0.90. Cabot Corporation has a 12 month low of $70.40 and a 12 month high of $117.46. The company has a current ratio of 2.13, a quick ratio of 1.41 and a debt-to-equity ratio of 0.66.
Cabot (NYSE:CBT - Get Free Report) last posted its earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share for the quarter, topping analysts' consensus estimates of $1.80 by $0.10. Cabot had a net margin of 11.14% and a return on equity of 25.68%. The business had revenue of $923.00 million for the quarter, compared to analyst estimates of $957.29 million. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. On average, equities research analysts predict that Cabot Corporation will post 7.57 EPS for the current year.
Cabot Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 11th. Investors of record on Friday, August 29th were paid a dividend of $0.45 per share. The ex-dividend date of this dividend was Friday, August 29th. This represents a $1.80 annualized dividend and a yield of 2.4%. Cabot's dividend payout ratio (DPR) is currently 23.53%.
Wall Street Analyst Weigh In
Separately, UBS Group set a $82.00 price objective on shares of Cabot and gave the stock a "neutral" rating in a report on Tuesday, August 5th. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and a consensus price target of $92.33.
Check Out Our Latest Analysis on CBT
Cabot Company Profile
(
Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Further Reading

Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.